Nanoviricides Stock Today
| NNVC Stock | USD 1.15 0.01 0.88% |
Performance3 of 100
| Odds Of DistressLess than 9
|
NanoViricides is trading at 1.15 as of the 24th of April 2024, a 0.88 percent increase since the beginning of the trading day. The stock's open price was 1.14. NanoViricides has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for NanoViricides are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 24th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 26th of October 2005 | Category Healthcare | Classification Health Care |
NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company was founded in 2005 and is based in Shelton, Connecticut. Nanoviricides operates under Biotechnology classification in the United States and is traded on AMEX Exchange. The company has 11.78 M outstanding shares of which 98.92 K shares are now shorted by private and institutional investors with about 3.94 trading days to cover. More on NanoViricides
Moving against NanoViricides Stock
| 0.51 | GILD | Gilead Sciences Earnings Call Tomorrow | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
NanoViricides Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. NanoViricides' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding NanoViricides or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Irach Taraporewala | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation Analysts covering NanoViricides report their recommendations after researching NanoViricides' financial statements, talking to executives and customers, or listening in on NanoViricides' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering NanoViricides. The NanoViricides consensus assessment is calculated by taking the average forecast from all of the analysts covering NanoViricides. | |||||
NanoViricides' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to NanoViricides' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand NanoViricides' financial leverage. It provides some insight into what part of NanoViricides' total assets is financed by creditors.
| |||||
NanoViricides (NNVC) is traded on NYSE MKT Exchange in USA. It is located in 1 Controls Drive, Shelton, CT, United States, 06484 and employs 7 people. NanoViricides is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.43 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate NanoViricides's market, we take the total number of its shares issued and multiply it by NanoViricides's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. NanoViricides conducts business under Biotechnology sector and is part of Health Care industry. The entity has 11.78 M outstanding shares of which 98.92 K shares are now shorted by private and institutional investors with about 3.94 trading days to cover.
NanoViricides currently holds about 14.07 M in cash with (5.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.21, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check NanoViricides Probability Of Bankruptcy
Ownership AllocationThe market capitalization of NanoViricides is $13.43 Million. NanoViricides secures 4.61 % of its outstanding shares held by insiders and 10.29 % owned by institutional investors. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check NanoViricides Ownership Details
NanoViricides Stock Price Odds Analysis
What are NanoViricides' target price odds to finish over the current price? Based on a normal probability distribution, the odds of NanoViricides jumping above the current price in 90 days from now is about 67.27%. The NanoViricides probability density function shows the probability of NanoViricides stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days NanoViricides has a beta of 0.2739. This indicates as returns on the market go up, NanoViricides average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding NanoViricides will be expected to be much smaller as well. Additionally, nanoViricides has an alpha of 0.1161, implying that it can generate a 0.12 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of NanoViricides to move above the current price in 90 days from now is about 67.27 (This NanoViricides probability density function shows the probability of NanoViricides Stock to fall within a particular range of prices over 90 days) .
NanoViricides Historical Income Statement
NanoViricides Income Statement is one of the three primary financial statements used for reporting NanoViricides's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of NanoViricides revenue and expense. NanoViricides Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, NanoViricides' Cost Of Revenue is projected to increase significantly based on the last few years of reporting. The current year's Net Interest Income is expected to grow to about 428.5 K, whereas Interest Expense is forecasted to decline to 1,025. View More FundamentalsNanoViricides Stock Against Markets
Picking the right benchmark for NanoViricides stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in NanoViricides stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for NanoViricides is critical whether you are bullish or bearish towards NanoViricides at a given time. Please also check how NanoViricides' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in NanoViricides without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
| All Next | Launch Module |
NanoViricides Corporate Directors
NanoViricides corporate directors refer to members of a NanoViricides board of directors. The board of directors generally takes responsibility for the NanoViricides' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of NanoViricides' board members must vote for the resolution. The NanoViricides board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Stanley Glick | Independent Director | Profile | |
| Milton Boniuk | Independent Director | Profile | |
| Mark Day | Independent Director | Profile | |
| Mukund Kulkarni | Independent Director | Profile |
How to buy NanoViricides Stock?
Before investing in NanoViricides, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in NanoViricides. To buy NanoViricides stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of NanoViricides. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase NanoViricides stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located NanoViricides stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased NanoViricides stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as NanoViricides, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy NanoViricides Stock please use our How to Invest in NanoViricides guide.
Already Invested in NanoViricides?
The danger of trading NanoViricides is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of NanoViricides is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than NanoViricides. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile NanoViricides is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether NanoViricides offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NanoViricides' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nanoviricides Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nanoviricides Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NanoViricides. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For information on how to trade NanoViricides Stock refer to our How to Trade NanoViricides Stock guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for NanoViricides Stock analysis
When running NanoViricides' price analysis, check to measure NanoViricides' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoViricides is operating at the current time. Most of NanoViricides' value examination focuses on studying past and present price action to predict the probability of NanoViricides' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoViricides' price. Additionally, you may evaluate how the addition of NanoViricides to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Stocks Directory Find actively traded stocks across global markets |
Is NanoViricides' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NanoViricides. If investors know NanoViricides will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NanoViricides listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.80) | Return On Assets (0.36) | Return On Equity (0.58) |
The market value of NanoViricides is measured differently than its book value, which is the value of NanoViricides that is recorded on the company's balance sheet. Investors also form their own opinion of NanoViricides' value that differs from its market value or its book value, called intrinsic value, which is NanoViricides' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NanoViricides' market value can be influenced by many factors that don't directly affect NanoViricides' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NanoViricides' value and its price as these two are different measures arrived at by different means. Investors typically determine if NanoViricides is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NanoViricides' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.